MedeAnalytics Recognized in Gartner’s Market Guide

MedeAnalytics was recently highlighted in Gartner’s Market Guide for Healthcare Provider Value-Based Performance Management Analytics (VBPMA). As noted in the guide, value-based performance management analytics solutions are the next-generation financial planning and modeling tools that health systems need to manage performance across volume, value, and risk-based contracts. Key findings reveal that the evolution of VBPMA continues as payers and health system board members pressure leaders to manage risk and demonstrate value.

The guide offers insights for healthcare CIOs in the process of defining their requirements for a potential analytics vendor. Gartner recommends that CIOs track emerging VBPMA vendors with solution capabilities that align to their enterprise priorities. Included in the guide is a checklist for CIOs to use to define their requirements, query vendors, and craft RFIs and RFPs as they uncover the tools that will provide the insights necessary for effective value-based performance management.

Within the report, MedeAnalytics was noted for its targeted functionality in enterprise financial analytics, which Gartner defines as the toolset required “to measure and analyze current changes and predict anticipated changes to variables that affect revenue and margins across all payment models.” These variables include changing payment models, regulatory program guidelines, population risk stratification, coverage, utilization, and care delivery costs.

MedeAnalytics was also emphasized for its ability to combine models such as cost accounting, revenue cycle management, or predictive, progressive risk stratification with VBPMA features, providing the advanced analytics that predict risk and financial performance. Additionally, the guide acknowledges the role that population health and quality management solutions play in helping health systems adapt to emerging measures and data requirements, while meeting growing buyer demands.

For more information, download the guide from Gartner or read more about our VBPMA solutions, Population Health and Quality Management.

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Leave a Comment





Get our take on industry trends

Crystal ball not necessary: predictive analytics helps health systems reduce denials

September 2, 2020

The idea of having a crystal ball to better understand what claims will be denied is an awesome concept. But one we can’t rely on. Thankfully, we have predictive analytics to take the place of a crystal ball.

Read on...

How did we get here? Hospital analytics and the new normal

July 15, 2020

I have heard the word “unprecedented” so many times in 2020 that it has lost its significance; many of us have become desensitized to the extraordinary changes in the world this year.

Read on...

How to help employer groups plan in a time of uncertainty

June 15, 2020

Employers and their sponsored health plans are thinking about next year’s benefit designs with a significant challenge not seen before: the effect of the coronavirus pandemic. There are important considerations to take into account before making any decisions about new or existing coverage. Becky Niehus, a director of Product Consulting at MedeAnalytics, explores these new issues and what employers can do to ensure employees are “covered.”

Read on...

Healthcare’s return to “normal” after COVID-19: Is it possible?

June 9, 2020

As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”

Read on...